These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 12495899

  • 1. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients.
    Zinzani PL, Martelli M, Bertini M, Gianni AM, Devizzi L, Federico M, Pangalis G, Michels J, Zucca E, Cantonetti M, Cortelazzo S, Wotherspoon A, Ferreri AJ, Zaja F, Lauria F, De Renzo A, Liberati MA, Falini B, Balzarotti M, Calderoni A, Zaccaria A, Gentilini P, Fattori PP, Pavone E, Angelopoulou MK, Alinari L, Brugiatelli M, Di Renzo N, Bonifazi F, Pileri SA, Cavalli F, International Extranodal Lymphoma Study Group (IELSG).
    Haematologica; 2002 Dec; 87(12):1258-64. PubMed ID: 12495899
    [Abstract] [Full Text] [Related]

  • 2. Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy.
    Zinzani PL, Martelli M, Bendandi M, De Renzo A, Zaccaria A, Pavone E, Bocchia M, Falini B, Gobbi M, Gherlinzoni F, Stefoni V, Tani M, Tura S.
    Haematologica; 2001 Feb; 86(2):187-91. PubMed ID: 11224489
    [Abstract] [Full Text] [Related]

  • 3. Primary mediastinal large B-cell lymphoma: results of intensive chemotherapy regimens (MACOP-B/VACOP-B) plus involved field radiotherapy on 53 patients. A single institution experience.
    Mazzarotto R, Boso C, Vianello F, Aversa MS, Chiarion-Sileni V, Trentin L, Zambello R, Muzzio PC, Fiore D, Sotti G.
    Int J Radiat Oncol Biol Phys; 2007 Jul 01; 68(3):823-9. PubMed ID: 17379431
    [Abstract] [Full Text] [Related]

  • 4. Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
    Todeschini G, Secchi S, Morra E, Vitolo U, Orlandi E, Pasini F, Gallo E, Ambrosetti A, Tecchio C, Tarella C, Gabbas A, Gallamini A, Gargantini L, Pizzuti M, Fioritoni G, Gottin L, Rossi G, Lazzarino M, Menestrina F, Paulli M, Palestro M, Cabras MG, Di Vito F, Pizzolo G.
    Br J Cancer; 2004 Jan 26; 90(2):372-6. PubMed ID: 14735179
    [Abstract] [Full Text] [Related]

  • 5. MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma.
    De Sanctis V, Finolezzi E, Osti MF, Grapulin L, Alfò M, Pescarmona E, Berardi F, Natalino F, Moleti ML, Di Rocco A, Enrici RM, Foà R, Martelli M.
    Int J Radiat Oncol Biol Phys; 2008 Nov 15; 72(4):1154-60. PubMed ID: 18472357
    [Abstract] [Full Text] [Related]

  • 6. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
    Zinzani PL, Stefoni V, Finolezzi E, Brusamolino E, Cabras MG, Chiappella A, Salvi F, Rossi A, Broccoli A, Martelli M.
    Clin Lymphoma Myeloma; 2009 Oct 15; 9(5):381-5. PubMed ID: 19858058
    [Abstract] [Full Text] [Related]

  • 7. [Mediastinal large B-cell lymphoma. A retrospective anatomic-clinical study of 26 cases].
    Tchen N, Eghbali H, Soubeyran P, Trojani M, Richaud P, Bonnel C, Quénel-Tueux N, Hoerni B.
    Bull Cancer; 1997 Jul 15; 84(7):704-8. PubMed ID: 9339196
    [Abstract] [Full Text] [Related]

  • 8. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y, Lu JJ, Ma X, Wang B, Hong X, Li X, Li J.
    Oral Oncol; 2008 Jan 15; 44(1):23-30. PubMed ID: 17306611
    [Abstract] [Full Text] [Related]

  • 9. Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete response to first-line regimens.
    Villela L, López-Guillermo A, Montoto S, Rives S, Bosch F, Perales M, Ferrer A, Esteve J, Colomo L, Campo E, Montserrat E.
    Cancer; 2001 Apr 15; 91(8):1557-62. PubMed ID: 11301405
    [Abstract] [Full Text] [Related]

  • 10. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ, Bu Q, Xia ZJ, Lin XB, Wang FH, Li YH, Peng YL, Pan ZH, Wang SS, Lin TY, Jiang WQ, Guan ZZ.
    Ai Zheng; 2006 Apr 15; 25(4):486-9. PubMed ID: 16613686
    [Abstract] [Full Text] [Related]

  • 11. [Autologous peripheral blood stem cell transplantation in the treatment of patients with primary large mediastinal B-cell lymphoma].
    He XH, Shi YK, Han XH, Zhou AP, Zhou SY, Liu P, Yang JL, Feng FY.
    Zhonghua Zhong Liu Za Zhi; 2003 Nov 15; 25(6):592-5. PubMed ID: 14690571
    [Abstract] [Full Text] [Related]

  • 12. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
    Yi JQ, Lin TY, He YJ, Huang HQ, Xia ZJ, Xia YF, Xu RH, Guo Y, Guan ZZ.
    Ai Zheng; 2006 Apr 15; 25(4):476-80. PubMed ID: 16613684
    [Abstract] [Full Text] [Related]

  • 13. Primary mediastinal large B-cell lymphoma.
    Martelli M, Ferreri AJ, Johnson P.
    Crit Rev Oncol Hematol; 2008 Dec 15; 68(3):256-63. PubMed ID: 18774728
    [Abstract] [Full Text] [Related]

  • 14. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.
    Ai Zheng; 2006 Dec 15; 25(12):1543-9. PubMed ID: 17166383
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of primary mediastinal large B-cell lymphomas].
    Schneider T, Tóth E, Molnár Z, Várady E, Deák B, Horváth A, Horváth GI, Eid H, Schneider K, Lovey J, Keresztes S, Esik O, Lengyel Z, Rosta A.
    Orv Hetil; 2004 Dec 12; 145(50):2531-7. PubMed ID: 15662753
    [Abstract] [Full Text] [Related]

  • 16. High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission.
    Papajik T, Raida L, Faber E, Vondrakova J, Prochazka V, Kubova Z, Skoumalova I, Jarosova M, M LK, Paucek B, Myslivecek M, Neoral C, Oral I, Jarkovsky J, Dusek L, Indrak K.
    Neoplasma; 2008 Dec 12; 55(3):215-21. PubMed ID: 18348654
    [Abstract] [Full Text] [Related]

  • 17. Safety and feasibility of CHOP/rituximab induction treatment followed by high-dose chemo/radiotherapy and autologous PBSC-transplantation in patients with previously untreated mantle cell or indolent B-cell-non-Hodgkin's lymphoma.
    Hess G, Flohr T, Huber C, Kolbe K, Derigs HG, Fischer T.
    Bone Marrow Transplant; 2003 May 12; 31(9):775-82. PubMed ID: 12732884
    [Abstract] [Full Text] [Related]

  • 18. High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience.
    Rodriguez J, Caballero MD, Gutierrez A, Gandarillas M, Sierra J, Lopez-Guillermo A, Sureda A, Zuazu J, Marin J, Arranz R, Carreras E, Leon A, De Sevilla AF, San Miguel JF, Conde E, GEL/TAMO Spanish Group.
    Haematologica; 2003 Dec 12; 88(12):1372-7. PubMed ID: 14687990
    [Abstract] [Full Text] [Related]

  • 19. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
    Sun XF, Su YS, Liu DG, Jiang WQ, He YJ, Lin TY, Huang HQ, Zhang L, Xia ZJ, Li YH, Zhou ZM, Chen XQ, Xia Y, Zhen ZJ, Guan ZZ.
    Ai Zheng; 2004 Aug 12; 23(8):933-8. PubMed ID: 15301718
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
    Wu HJ, Zhang QY, Chen DF, Guan XJ, Zhang BL, Ma J.
    Ai Zheng; 2005 Dec 12; 24(12):1498-502. PubMed ID: 16351800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.